The French ministers of Agriculture and Economy highlighted the importance of consumer protection and have notified the European Commission, seeking EU-level measures in response to the situation.

An arrêté issued on April 15, 2025, prohibits the introduction of Garcinia cambogia supplements from EU member states and imports from third countries, effective immediately.

These supplements have been linked to severe adverse effects, primarily due to the presence of hydroxycitric acid.

This decision follows a recommendation from the National Agency for Food, Environmental and Occupational Health Safety (Anses), which cautioned against the consumption of these supplements in early March.

As a result of the identified acute health risks, existing stocks of Garcinia cambogia supplements on the French market are to be withdrawn.

On April 18, 2025, the French government announced a suspension on the sale and importation of Garcinia cambogia-based appetite suppressants due to serious health risks.

Food sector operators are mandated to recall any Garcinia cambogia dietary supplements they have marketed under the new regulations.

Despite being banned in medicines since 2012, Garcinia cambogia continued to be marketed in dietary supplements, with approximately 340 products available, primarily online.

From 2009 to March 2024, France reported 38 cases of serious adverse effects linked to Garcinia cambogia, including complications related to the liver, psychiatric issues, digestive problems, cardiac events, and muscular complications.

Current European regulations allow health claims regarding weight control and fat storage reduction associated with Garcinia cambogia, but these claims are now under review by the European Food Safety Authority (EFSA).